PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
503.87 - 512.55
344.79 - 555.45
23.62M / 20.39M (Avg.)
37.30 | 13.67
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
2.14%
Revenue growth below 50% of CRWD's 5.94%. Michael Burry would check for competitive disadvantage risks.
1.82%
Cost growth less than half of CRWD's 7.31%. David Dodd would verify if cost advantage is structural.
2.18%
Gross profit growth below 50% of CRWD's 5.45%. Michael Burry would check for structural issues.
0.04%
Margin expansion while CRWD shows decline. John Neff would investigate competitive advantages.
20.55%
R&D growth above 1.5x CRWD's 3.75%. Michael Burry would check for spending discipline.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
5.50%
Operating expenses growth above 1.5x CRWD's 3.48%. Michael Burry would check for inefficiency.
4.91%
Total costs growth 1.1-1.25x CRWD's 4.38%. Bill Ackman would demand justification.
No Data
No Data available this quarter, please select a different quarter.
-5.71%
Both companies reducing D&A. Martin Whitman would check industry patterns.
-3.39%
Both companies show EBITDA decline. Martin Whitman would check industry conditions.
-0.91%
Both companies show margin pressure. Martin Whitman would check industry conditions.
-3.10%
Operating income decline while CRWD shows 9.37% growth. Joel Greenblatt would examine position.
-5.13%
Operating margin decline while CRWD shows 14.45% growth. Joel Greenblatt would examine position.
-65.12%
Other expenses reduction while CRWD shows 18.80% growth. Joel Greenblatt would examine advantage.
-7.60%
Pre-tax income decline while CRWD shows 20.26% growth. Joel Greenblatt would examine position.
-9.54%
Pre-tax margin decline while CRWD shows 24.73% growth. Joel Greenblatt would examine position.
-8.67%
Both companies reducing tax expense. Martin Whitman would check patterns.
-7.07%
Net income decline while CRWD shows 29.52% growth. Joel Greenblatt would examine position.
-9.02%
Net margin decline while CRWD shows 33.47% growth. Joel Greenblatt would examine position.
-12.50%
EPS decline while CRWD shows 29.55% growth. Joel Greenblatt would examine position.
-12.50%
Diluted EPS decline while CRWD shows 29.55% growth. Joel Greenblatt would examine position.
6.44%
Share count reduction below 50% of CRWD's 0.59%. Michael Burry would check for concerns.
6.44%
Diluted share reduction below 50% of CRWD's 0.59%. Michael Burry would check for concerns.